Looby,Michael

Institution: Daiichi Sankyo Pharma Development, Edison, NJ, USA

Top Collaborators: Wu K, Mercier F, David OJ, Schmouder RL

Research Interests: Adjustment, Administration, Bioavailability, Body Weight, Cells, Central Nervous System, Concentration, Lymphocytes, Multiple Sclerosis, Nervous System, Oral Administration, Pharmacokinetics, Phosphorylation, Population, Sclerosis, Sphingosine, Sphingosine 1-phosphate Receptor, Time, Treatment